한빛사 논문
Heounjeong Go MD*,†, Yoon Kyung Jeon MD, PhD*,†, Hyo Jin Park MD‡, Sook-Whan Sung MD, PhD§, Jeong-Wook Seo MD, PhD*, Doo Hyun Chung MD, PhD*,#
*Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea
†Tumor Immunity Medical Research Center, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
‡Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Kyeonggi-do, Republic of Korea
§Department of Thoracic Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea
D.H.C. and Y.K.J. contributed equally to this work as corresponding authors.
#Corresponding author
Abstract
Introduction
Activation of MET, either by increased gene copy number (GCN) or mutation, has been detected in various cancers. We investigate the clinicopathologic features of MET gene copy in nonsmall cell lung cancer (NSCLC).
Methods
Tumor tissues were obtained from 180 resected NSCLCs, including 97 squamous cell carcinomas (SCCs) and 72 adenocarcinomas. No patient received epidermal growth factor receptor (EGFR)-targeted therapy. EGFR and MET GCNs were studied using fluorescence in situ hybridization (FISH) and were estimated according to the University of Colorado Cancer Center (UCCC) criteria. For MET, we also assessed GCNs using the Cappuzzo system.
Results
FISH-positive MET was observed in 16.7% using the UCCC criteria; specifically, amplification was seen in 3.9% and high polysomy in 12.8%. FISH-positive MET status was significantly correlated with FISH-positive EGFR (p = 0.003). In the Cappuzzo system, high MET GCN (mean, ≥5 copies/cell) was found in 6.7% and also associated with FISH-positive EGFR (p = 0.031). MET gene copy status was not associated with gender, smoking history, histology, or stage. However, true MET amplification was more frequent in patients with SCC than in those with adenocarcinoma. FISH-positive MET status predicted worse survival in patients with NSCLC at advanced stages (p = 0.034) and in patients with SCC (p = 0.028). In multivariate analyses, increased MET GCN was significantly associated with shorter survival in patients with SCC, as analyzed using both the UCCC and Cappuzzo criteria (p = 0.019 and 0.008).
Conclusions
Our results suggest that increased MET GCN would be an independent poor prognostic factor in SCC of the lung.
논문정보
관련 링크
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기